Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer
Zimmer Biomet announced the appointment of Jonathan M. Vigdorchik, M.D., as Chief Science, Technology and Medical Affairs Officer, effective April 14, 2026.
Dr. Vigdorchik will oversee the company's global technology portfolio including AI, robotics, smart implants, and data, as well as medical education strategy and Global Advisory Board.
He reports to Ivan Tornos, Chairman, President and CEO.
Previously, Dr. Vigdorchik served as Zimmer Biomet's Chief Medical Technology Advisor for Adult Reconstruction and Hip Implants.
He is a board-certified orthopedic surgeon at Hospital for Special Surgery (HSS) in New York, specializing in hip and knee replacement, and Associate Professor at Weill Cornell Medical College.
The announcement was made on April 7, 2026.